Thrombin-, bradykinin-, and arachidonic acid-induced Ca2+ signaling in Ehrlich ascites tumor cells

Stimulation ofsingle Ehrlich ascites tumor cells with agonists (bradykinin, thrombin)and with arachidonic acid (AA) induces increases in the freeintracellular Ca²⁺ concentration([Ca²⁺]_i)in the presence and absence of extracellularCa²⁺, measured using theCa²⁺-sensitive probe fura 2. Sequential stimulation with two agonists elicits sequential increasesin[Ca²⁺]_i,unlike addition of the same agonist twice. Bradykinin and thrombin haveadditive effects on[Ca²⁺]_iin Ca²⁺-free medium. Thephosphoinositidase C inhibitor U-73122 inhibits the agonist-inducedincreases in[Ca²⁺]_i,whereas ryanodine has no effect. Pretreatment of cells in Ca²⁺-free medium with thapsigarginabolishes the bradykinin-induced increase in[Ca²⁺]_ibut not the response to thrombin. The AA-induced response is notinhibited by U-73122 and cannot be mimicked by the inactive structuralanalog trifluoromethylarachidonyl ketone. Pretreatment of the cellswith 50 µM AA (but not with 10 µM AA) abolishes the agonist-inducedincrease in[Ca²⁺]_i.Thus bradykinin, thrombin, and AA induce increases in[Ca²⁺]_iin Ehrlich cells due to Ca²⁺ entryand release from intracellular stores. Thrombin causes release ofCa²⁺ from an intracellular storethat is insensitive to bradykinin and is not depleted by thapsigarginbut is depleted by AA.